• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

墨西哥威克萨卡族人群中多发性硬化症风险单倍型 HLA-DR2 的标签多态性缺失。

Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.

机构信息

Departamento de Disciplinas Filosóficas, Metodológicas e Instrumentales, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Sierra Mojada 950, 44340, Guadalajara, Jalisco, Mexico.

Laboratorio de Inmunodeficiencias y Retrovirus Humanos, División de Neurociencias, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, Mexico.

出版信息

Immunogenetics. 2018 Aug;70(8):547-551. doi: 10.1007/s00251-018-1052-8. Epub 2018 Feb 3.

DOI:10.1007/s00251-018-1052-8
PMID:29397401
Abstract

The HLA-DRB115:01 allele has a demonstrated risk for the development of multiple sclerosis (MS) in most populations around the world. The single nucleotide polymorphism (SNP) rs3129934 is found in linkage disequilibrium with the risk haplotype formed by the HLA-DRB115:01 and HLA-DQB106:02 alleles, and it is considered a reliable marker of the presence of this haplotype. Native Americans have a null or low prevalence of MS. In this study, we sought to identify the frequency of rs3129934 in the Wixárika ethnic group as well as in Mestizo (mixed race) patients with MS and in controls from western Mexico. Through real-time polymerase chain reaction (PCR) using TaqMan probes, we analyzed the allele and genotype frequencies of rs3129934 in Mestizo individuals with and without MS and in 73 Wixárika subjects from the state of Jalisco, Mexico. The Wixárika subjects were homozygote for the C allele of rs3129934. The allele and genotype frequency in Mestizos with MS was similar to that of other MS populations with Caucasian ancestry. The absence of the T risk allele rs3129934 (associated with the haplotype HLA-DRB115:01, HLA-DQ1*06:02) in this sample of Wixárika subjects is consistent with the unreported MS in this Amerindian group, related to absence of such paramount genetic risk factor.

摘要

HLA-DRB115:01 等位基因在世界上大多数人群中都被证实与多发性硬化症 (MS) 的发生有关。单核苷酸多态性 (SNP) rs3129934 与由 HLA-DRB115:01 和 HLA-DQB106:02 等位基因形成的风险单倍型连锁不平衡,被认为是该单倍型存在的可靠标志物。美洲原住民的 MS 患病率较低或为零。在这项研究中,我们试图确定 Wixárika 族群以及来自墨西哥西部的 MS 混合人种患者和对照组中 rs3129934 的频率。通过使用 TaqMan 探针的实时聚合酶链反应 (PCR),我们分析了 Mestizo 个体中 rs3129934 的等位基因和基因型频率,包括有和没有 MS 的个体,以及来自墨西哥哈利斯科州的 73 名 Wixárika 个体。Wixárika 个体是 rs3129934 的 C 等位基因纯合子。Mestizo 中 MS 的等位基因和基因型频率与其他具有白种人祖先的 MS 人群相似。在这个 Wixárika 样本中,T 风险等位基因 rs3129934(与 HLA-DRB115:01、HLA-DQ1*06:02 单倍型相关)的缺失,与该印第安人群体中未报告的 MS 一致,这与缺乏这种首要遗传风险因素有关。

相似文献

1
Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.墨西哥威克萨卡族人群中多发性硬化症风险单倍型 HLA-DR2 的标签多态性缺失。
Immunogenetics. 2018 Aug;70(8):547-551. doi: 10.1007/s00251-018-1052-8. Epub 2018 Feb 3.
2
Polymorphism and distribution of HLA-DR2 alleles in Mexican populations.墨西哥人群中HLA - DR2等位基因的多态性与分布
Hum Immunol. 2001 Mar;62(3):286-91. doi: 10.1016/s0198-8859(00)00258-5.
3
Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland.HLA-II类基因分型在冰岛多发性硬化易感性中复杂作用的证据。
Neurology. 1996 Apr;46(4):1107-11. doi: 10.1212/wnl.46.4.1107.
4
Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis.香港华人中新型HLA - DR2相关单倍型表明DQB1*0602等位基因与多发性硬化症易感性有关。
Eur J Immunogenet. 1992 Feb-Apr;19(1-2):11-9. doi: 10.1111/j.1744-313x.1992.tb00043.x.
5
Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2.与HLA抗原结合相关的多态性区域的多发性硬化症相关氨基酸仅限于HLA - DR2。
Hum Immunol. 2000 Oct;61(10):1021-30. doi: 10.1016/s0198-8859(00)00173-7.
6
The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.斯洛伐克人群中HLA - DRB1和HLA - DQB1等位基因与多发性硬化症遗传易感性的关联。
Neurol Res. 2015;37(12):1060-7. doi: 10.1080/01616412.2015.1115212. Epub 2016 Jan 8.
7
HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.HLA - DR2对多发性硬化易感性的剂量效应及其对病程的影响。
Am J Hum Genet. 2003 Mar;72(3):710-6. doi: 10.1086/367781. Epub 2003 Jan 28.
8
HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.HLA-A 赋予多发性硬化症风险 HLA-DRB1 独立影响。
PLoS One. 2007 Jul 25;2(7):e664. doi: 10.1371/journal.pone.0000664.
9
DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.DQB1*0602等位基因在西班牙马拉加的患者中与多发性硬化症有很强的关联。
J Neurol. 2004 Apr;251(4):440-4. doi: 10.1007/s00415-004-0350-2.
10
Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.人类白细胞抗原在以色列低频DRB1*1501多发性硬化症患者中的遗传作用证据。
Mult Scler. 1999 Dec;5(6):410-5. doi: 10.1177/135245859900500i607.

本文引用的文献

1
Multiple Sclerosis in Latin Americans: Genetic Aspects.拉丁美洲人的多发性硬化症:遗传学方面
Curr Neurol Neurosci Rep. 2017 Aug;17(8):57. doi: 10.1007/s11910-017-0768-4.
2
Multiple sclerosis epidemiology in Latin America: An updated survey.拉丁美洲的多发性硬化症流行病学:最新调查。
Mult Scler J Exp Transl Clin. 2017 Jun 13;3(2):2055217317715050. doi: 10.1177/2055217317715050. eCollection 2017 Apr-Jun.
3
HLA-DMB in Amerindians: Specific linkage of DMB*01:03:01/DRB1 alleles.美洲印第安人中的HLA - DMB:DMB*01:03:01/DRB1等位基因的特异性连锁
Hum Immunol. 2016 May;77(5):389-94. doi: 10.1016/j.humimm.2016.02.011. Epub 2016 Mar 2.
4
The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases.HLA-DRB1(∗)13 在自身免疫性疾病中的保护作用。
J Immunol Res. 2015;2015:948723. doi: 10.1155/2015/948723. Epub 2015 Oct 29.
5
An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis.多发性硬化症免疫发病机制、诊断及治疗的最新进展
Brain Behav. 2015 Sep;5(9):e00362. doi: 10.1002/brb3.362. Epub 2015 Aug 3.
6
Class II HLA interactions modulate genetic risk for multiple sclerosis.II类人类白细胞抗原相互作用调节多发性硬化症的遗传风险。
Nat Genet. 2015 Oct;47(10):1107-1113. doi: 10.1038/ng.3395. Epub 2015 Sep 7.
7
Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review.复发缓解型和原发进展型多发性硬化症发病相关的危险因素:一项系统综述。
Biomed Res Int. 2015;2015:817238. doi: 10.1155/2015/817238. Epub 2015 Jan 31.
8
Genomewide admixture study in Mexican Mestizos with multiple sclerosis.针对患有多发性硬化症的墨西哥梅斯蒂索人的全基因组混合研究。
Clin Neurol Neurosurg. 2015 Mar;130:55-60. doi: 10.1016/j.clineuro.2014.11.026. Epub 2014 Dec 24.
9
Modifiable environmental factors in multiple sclerosis.多发性硬化症中可改变的环境因素。
Arq Neuropsiquiatr. 2014 Nov;72(11):889-94. doi: 10.1590/0004-282x20140159.
10
Multiple sclerosis care in Latin America.拉丁美洲的多发性硬化症护理。
Neurology. 2014 May 6;82(18):1660-1. doi: 10.1212/WNL.0000000000000376.